H Grant Skaggs Jr

Array ( [id] => 9375244 [patent_doc_number] => 08679504 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-25 [patent_title] => 'Poultry viral materials and methods related thereto' [patent_app_type] => utility [patent_app_number] => 12/951352 [patent_app_country] => US [patent_app_date] => 2010-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 21814 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12951352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9375244 [patent_doc_number] => 08679504 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-25 [patent_title] => 'Poultry viral materials and methods related thereto' [patent_app_type] => utility [patent_app_number] => 12/951352 [patent_app_country] => US [patent_app_date] => 2010-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 21814 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12951352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7567343 [patent_doc_number] => 20110287406 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-24 [patent_title] => 'Novel HCV core+1 protein, methods for diagnosis of HCV infections, prophylaxis, and for screening of anti-HCV agents' [patent_app_type] => utility [patent_app_number] => 12/926387 [patent_app_country] => US [patent_app_date] => 2010-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 10170 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20110287406.pdf [firstpage_image] =>[orig_patent_app_number] => 12926387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9134417 [patent_doc_number] => 20130295131 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-07 [patent_title] => 'GENERATION OF ANTIGENIC VIRUS-LIKE PARTICLES THROUGH PROTEIN-PROTEIN LINKAGES' [patent_app_type] => utility [patent_app_number] => 13/883459 [patent_app_country] => US [patent_app_date] => 2010-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 2170 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13883459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10149030 [patent_doc_number] => 09181306 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-10 [patent_title] => 'Insertion of foreign genes in rubella virus and their stable expression in a live, attenuated viral vaccine' [patent_app_type] => utility [patent_app_number] => 13/501893 [patent_app_country] => US [patent_app_date] => 2010-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 30621 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13501893 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5984707 [patent_doc_number] => 20110097358 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'RESPIRATORY SYNCYTIAL VIRUS (RSV) VIRUS-LIKE PARTICLES (VLPs)' [patent_app_type] => utility [patent_app_number] => 12/902733 [patent_app_country] => US [patent_app_date] => 2010-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 15615 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20110097358.pdf [firstpage_image] =>[orig_patent_app_number] => 12902733 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8429697 [patent_doc_number] => 20120251572 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-04 [patent_title] => 'HEPATITIS C VIRUS VACCINE COMPOSITION' [patent_app_type] => utility [patent_app_number] => 13/499009 [patent_app_country] => US [patent_app_date] => 2010-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 16347 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13499009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9844482 [patent_doc_number] => 08946398 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-03 [patent_title] => 'Infectious hepatitis C viruses of genotype 3A and 4A and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/499663 [patent_app_country] => US [patent_app_date] => 2010-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 18020 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13499663 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11784022 [patent_doc_number] => 09393299 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-07-19 [patent_title] => 'Composition for treating HBV infection' [patent_app_type] => utility [patent_app_number] => 13/388826 [patent_app_country] => US [patent_app_date] => 2010-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 18 [patent_no_of_words] => 28477 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 193 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13388826 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9254852 [patent_doc_number] => 08618270 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-31 [patent_title] => 'Oligonucleotide analog and method for treating flavivirus infections' [patent_app_type] => utility [patent_app_number] => 12/848873 [patent_app_country] => US [patent_app_date] => 2010-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 18 [patent_no_of_words] => 14744 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12848873 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9139800 [patent_doc_number] => 08580256 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-12 [patent_title] => 'Stabilized anti-hepatitis B (HBV) antibody formulations' [patent_app_type] => utility [patent_app_number] => 12/821593 [patent_app_country] => US [patent_app_date] => 2010-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5805 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12821593 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5970399 [patent_doc_number] => 20110151431 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'DETECTION OF XENOTROPIC MURINE LEUKEMIA VIRUS' [patent_app_type] => utility [patent_app_number] => 12/818893 [patent_app_country] => US [patent_app_date] => 2010-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 24471 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20110151431.pdf [firstpage_image] =>[orig_patent_app_number] => 12818893 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6000605 [patent_doc_number] => 20110117056 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'DIAGNOSIS AND TREATMENT OF DISEASES OR DISORDERS ASSOCIATED WITH XENOTROPIC MURINE LEUKEMIA VIRUS' [patent_app_type] => utility [patent_app_number] => 12/818880 [patent_app_country] => US [patent_app_date] => 2010-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 26016 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20110117056.pdf [firstpage_image] =>[orig_patent_app_number] => 12818880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5952279 [patent_doc_number] => 20110033418 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'TREATMENT OF DISEASES CAUSED BY VIRAL INFECTION' [patent_app_type] => utility [patent_app_number] => 12/817247 [patent_app_country] => US [patent_app_date] => 2010-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8898 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20110033418.pdf [firstpage_image] =>[orig_patent_app_number] => 12817247 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6392339 [patent_doc_number] => 20100303851 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'IMMUNOSTIMULATION BY CHEMICALLY MODIFIED RNA' [patent_app_type] => utility [patent_app_number] => 12/791233 [patent_app_country] => US [patent_app_date] => 2010-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11242 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0303/20100303851.pdf [firstpage_image] =>[orig_patent_app_number] => 12791233 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6262283 [patent_doc_number] => 20100297080 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'GENETIC MARKERS ASSOCIATED WITH INTERFERON-ALPHA RESPONSE' [patent_app_type] => utility [patent_app_number] => 12/785060 [patent_app_country] => US [patent_app_date] => 2010-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 24264 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297080.pdf [firstpage_image] =>[orig_patent_app_number] => 12785060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6602127 [patent_doc_number] => 20100322972 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'HCV Vaccines For Chronic HCV Patients' [patent_app_type] => utility [patent_app_number] => 12/774449 [patent_app_country] => US [patent_app_date] => 2010-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4619 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0322/20100322972.pdf [firstpage_image] =>[orig_patent_app_number] => 12774449 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6503325 [patent_doc_number] => 20100260713 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'Compositions and Methods for the Inhibition of Hepatitis C Viral Replication with Structural Analogs' [patent_app_type] => utility [patent_app_number] => 12/757828 [patent_app_country] => US [patent_app_date] => 2010-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10195 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20100260713.pdf [firstpage_image] =>[orig_patent_app_number] => 12757828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6510332 [patent_doc_number] => 20100261195 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'RAPID ANTEMORTEM DETECTION OF INFECTIOUS AGENTS' [patent_app_type] => utility [patent_app_number] => 12/731776 [patent_app_country] => US [patent_app_date] => 2010-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 14939 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20100261195.pdf [firstpage_image] =>[orig_patent_app_number] => 12731776 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7784632 [patent_doc_number] => 20120046188 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-23 [patent_title] => 'Solid Support for HCV Detection' [patent_app_type] => utility [patent_app_number] => 13/258125 [patent_app_country] => US [patent_app_date] => 2010-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11500 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20120046188.pdf [firstpage_image] =>[orig_patent_app_number] => 13258125 [rel_patent_id] =>[rel_patent_doc_number] =>)